Slot System
Featured Buckets
Featured Buckets Admin
Reverse Chronological Sort

Epileptic Medications Linked to Stroke in Patients with Alzheimer Disease

Article Type
Changed
Tue, 11/06/2018 - 11:18
Display Headline
Epileptic Medications Linked to Stroke in Patients with Alzheimer Disease
J Am Heart Assoc; 2018 Sept 18; Sarycheva et al.

Among people with Alzheimer Disease, the risk of developing a stroke is significantly greater if they are using antiepileptic drugs, according to a large study published in the Journal of the American Heart Association.

  • The Medication Use and Alzheimer’s Disease cohort, which includes all the people in Finland who have been clinically diagnosed with Alzheimer disease (70,718) from 2005 to 2011, was analyzed to look for a correlation between the disease and antiepileptic drug use.
  • Patients who had used the medications were about 37% more likely to have experienced a stroke, compared to nondrug users (hazard ratio [HR], 1.37).
  • The likelihood of having a stroke in this patient population was greatest during the first 3 months of taking antiepileptic medication (HR, 2.36).
  • The association between drug use and ischemic stroke was less than that observed between drug use and hemorrhagic stroke (HR, 1.34 vs 1.44).

 

Sarycheva T, Lavikainen P, Taipale H, et al. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People with Alzheimer Disease: A Matched Cohort Study. J Am Heart Assoc. 2018; 7: e009742. DOI: 10.1161/JAHA.118.009742.

Publications
Topics
Sections
J Am Heart Assoc; 2018 Sept 18; Sarycheva et al.
J Am Heart Assoc; 2018 Sept 18; Sarycheva et al.

Among people with Alzheimer Disease, the risk of developing a stroke is significantly greater if they are using antiepileptic drugs, according to a large study published in the Journal of the American Heart Association.

  • The Medication Use and Alzheimer’s Disease cohort, which includes all the people in Finland who have been clinically diagnosed with Alzheimer disease (70,718) from 2005 to 2011, was analyzed to look for a correlation between the disease and antiepileptic drug use.
  • Patients who had used the medications were about 37% more likely to have experienced a stroke, compared to nondrug users (hazard ratio [HR], 1.37).
  • The likelihood of having a stroke in this patient population was greatest during the first 3 months of taking antiepileptic medication (HR, 2.36).
  • The association between drug use and ischemic stroke was less than that observed between drug use and hemorrhagic stroke (HR, 1.34 vs 1.44).

 

Sarycheva T, Lavikainen P, Taipale H, et al. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People with Alzheimer Disease: A Matched Cohort Study. J Am Heart Assoc. 2018; 7: e009742. DOI: 10.1161/JAHA.118.009742.

Among people with Alzheimer Disease, the risk of developing a stroke is significantly greater if they are using antiepileptic drugs, according to a large study published in the Journal of the American Heart Association.

  • The Medication Use and Alzheimer’s Disease cohort, which includes all the people in Finland who have been clinically diagnosed with Alzheimer disease (70,718) from 2005 to 2011, was analyzed to look for a correlation between the disease and antiepileptic drug use.
  • Patients who had used the medications were about 37% more likely to have experienced a stroke, compared to nondrug users (hazard ratio [HR], 1.37).
  • The likelihood of having a stroke in this patient population was greatest during the first 3 months of taking antiepileptic medication (HR, 2.36).
  • The association between drug use and ischemic stroke was less than that observed between drug use and hemorrhagic stroke (HR, 1.34 vs 1.44).

 

Sarycheva T, Lavikainen P, Taipale H, et al. Antiepileptic Drug Use and the Risk of Stroke Among Community-Dwelling People with Alzheimer Disease: A Matched Cohort Study. J Am Heart Assoc. 2018; 7: e009742. DOI: 10.1161/JAHA.118.009742.

Publications
Publications
Topics
Article Type
Display Headline
Epileptic Medications Linked to Stroke in Patients with Alzheimer Disease
Display Headline
Epileptic Medications Linked to Stroke in Patients with Alzheimer Disease
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 11/06/2018 - 11:15
Un-Gate On Date
Tue, 11/06/2018 - 11:15
Use ProPublica
CFC Schedule Remove Status
Tue, 11/06/2018 - 11:15

Hybrid Depth vs Standard Microwire Electrodes

Article Type
Changed
Tue, 11/06/2018 - 11:17
Display Headline
Hybrid Depth vs Standard Microwire Electrodes
Stereotact Funct Neurosurg; ePub 2018 Oct 16; Carlson et al.

Standard depth invasive electrodes are typically used to precisely locate areas of the brain that are responsible for seizures in patients with medically refractory epilepsy, but a recent analysis suggests that hybrid depth microwire electrodes may be just as effective and just as safe.

  • Investigators at Cedars-Sinai Medical Center reviewed 53 cases of refractory epilepsy who had surgery between 2006 and 2017.
  • The analysis included 555 electrodes and revealed a complication rate of 2.3% per electrode and a per case rate of 20.8%; no infections or deaths were reported.
  • The researchers did not uncover a difference in complication rates between standard and hybrid depth electrodes.
  • Hybrid depth electrodes were as reliable as standard electrodes in pinpointing seizure onset zones.

Carlson AA, Rutishauser U, Mamelak AN. Safety and utility of hybrid depth electrodes for seizure localization and single-unit neuronal recording [published online ahead of print Oct 16, 2018]. Stereotact Funct Neurosurg.

Publications
Topics
Sections
Stereotact Funct Neurosurg; ePub 2018 Oct 16; Carlson et al.
Stereotact Funct Neurosurg; ePub 2018 Oct 16; Carlson et al.

Standard depth invasive electrodes are typically used to precisely locate areas of the brain that are responsible for seizures in patients with medically refractory epilepsy, but a recent analysis suggests that hybrid depth microwire electrodes may be just as effective and just as safe.

  • Investigators at Cedars-Sinai Medical Center reviewed 53 cases of refractory epilepsy who had surgery between 2006 and 2017.
  • The analysis included 555 electrodes and revealed a complication rate of 2.3% per electrode and a per case rate of 20.8%; no infections or deaths were reported.
  • The researchers did not uncover a difference in complication rates between standard and hybrid depth electrodes.
  • Hybrid depth electrodes were as reliable as standard electrodes in pinpointing seizure onset zones.

Carlson AA, Rutishauser U, Mamelak AN. Safety and utility of hybrid depth electrodes for seizure localization and single-unit neuronal recording [published online ahead of print Oct 16, 2018]. Stereotact Funct Neurosurg.

Standard depth invasive electrodes are typically used to precisely locate areas of the brain that are responsible for seizures in patients with medically refractory epilepsy, but a recent analysis suggests that hybrid depth microwire electrodes may be just as effective and just as safe.

  • Investigators at Cedars-Sinai Medical Center reviewed 53 cases of refractory epilepsy who had surgery between 2006 and 2017.
  • The analysis included 555 electrodes and revealed a complication rate of 2.3% per electrode and a per case rate of 20.8%; no infections or deaths were reported.
  • The researchers did not uncover a difference in complication rates between standard and hybrid depth electrodes.
  • Hybrid depth electrodes were as reliable as standard electrodes in pinpointing seizure onset zones.

Carlson AA, Rutishauser U, Mamelak AN. Safety and utility of hybrid depth electrodes for seizure localization and single-unit neuronal recording [published online ahead of print Oct 16, 2018]. Stereotact Funct Neurosurg.

Publications
Publications
Topics
Article Type
Display Headline
Hybrid Depth vs Standard Microwire Electrodes
Display Headline
Hybrid Depth vs Standard Microwire Electrodes
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 11/06/2018 - 11:15
Un-Gate On Date
Tue, 11/06/2018 - 11:15
Use ProPublica
CFC Schedule Remove Status
Tue, 11/06/2018 - 11:15

Abnormal EEG in Patients with Autism May Signal Developmental Problems

Article Type
Changed
Tue, 11/06/2018 - 11:16
Display Headline
Abnormal EEG in Patients with Autism May Signal Developmental Problems
Epilepsy Behav; ePub 2018 Oct 17; Capal et al.

Children with autism who also have an abnormal EEG or epilepsy are more likely to experience problems with developmental and adaptive functioning, according to an analysis of 443 patients with autism spectrum disorder (ASD).

  • The medical records of children with autism were reviewed by researchers at Cincinnati Children’s Hospital Medical Center.
  • The children were divided into 3 categories: those with ASD, no epilepsy, and abnormal EEG results; those with ASD, no epilepsy, and normal EEG; and those with ASD and epilepsy.
  • Among 372 patients with ASD without epilepsy, 25.5% had an abnormal EEG; these patients were more likely to have more impaired adaptive functioning when compared to patients with normal EEG readings.
  • Children with abnormal EEG readings presented with similar abnormalities to the group with epilepsy.
  • Patients with epilepsy had lower scores on all the tests that measure developmental and adaptive functioning, when compared to those with normal EEG readings.

Capal JK, Carosella C, Corbin E, et al. EEG endophenotypes in autism spectrum disorder [published online ahead of print Oct 17, 2018]. Epilepsy Behav.  

Publications
Topics
Sections
Epilepsy Behav; ePub 2018 Oct 17; Capal et al.
Epilepsy Behav; ePub 2018 Oct 17; Capal et al.

Children with autism who also have an abnormal EEG or epilepsy are more likely to experience problems with developmental and adaptive functioning, according to an analysis of 443 patients with autism spectrum disorder (ASD).

  • The medical records of children with autism were reviewed by researchers at Cincinnati Children’s Hospital Medical Center.
  • The children were divided into 3 categories: those with ASD, no epilepsy, and abnormal EEG results; those with ASD, no epilepsy, and normal EEG; and those with ASD and epilepsy.
  • Among 372 patients with ASD without epilepsy, 25.5% had an abnormal EEG; these patients were more likely to have more impaired adaptive functioning when compared to patients with normal EEG readings.
  • Children with abnormal EEG readings presented with similar abnormalities to the group with epilepsy.
  • Patients with epilepsy had lower scores on all the tests that measure developmental and adaptive functioning, when compared to those with normal EEG readings.

Capal JK, Carosella C, Corbin E, et al. EEG endophenotypes in autism spectrum disorder [published online ahead of print Oct 17, 2018]. Epilepsy Behav.  

Children with autism who also have an abnormal EEG or epilepsy are more likely to experience problems with developmental and adaptive functioning, according to an analysis of 443 patients with autism spectrum disorder (ASD).

  • The medical records of children with autism were reviewed by researchers at Cincinnati Children’s Hospital Medical Center.
  • The children were divided into 3 categories: those with ASD, no epilepsy, and abnormal EEG results; those with ASD, no epilepsy, and normal EEG; and those with ASD and epilepsy.
  • Among 372 patients with ASD without epilepsy, 25.5% had an abnormal EEG; these patients were more likely to have more impaired adaptive functioning when compared to patients with normal EEG readings.
  • Children with abnormal EEG readings presented with similar abnormalities to the group with epilepsy.
  • Patients with epilepsy had lower scores on all the tests that measure developmental and adaptive functioning, when compared to those with normal EEG readings.

Capal JK, Carosella C, Corbin E, et al. EEG endophenotypes in autism spectrum disorder [published online ahead of print Oct 17, 2018]. Epilepsy Behav.  

Publications
Publications
Topics
Article Type
Display Headline
Abnormal EEG in Patients with Autism May Signal Developmental Problems
Display Headline
Abnormal EEG in Patients with Autism May Signal Developmental Problems
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Tue, 11/06/2018 - 11:15
Un-Gate On Date
Tue, 11/06/2018 - 11:15
Use ProPublica
CFC Schedule Remove Status
Tue, 11/06/2018 - 11:15

Diagnosis of Epilepsy with Myoclonic-Atonic Seizures Often Changes

Article Type
Changed
Wed, 10/24/2018 - 14:53
Display Headline
Diagnosis of Epilepsy with Myoclonic-Atonic Seizures Often Changes
Epilepsy Res; 2018 Nov; Eschbach et al.

Pediatric patients who have been initially diagnosed with epilepsy with myoclonic-atonic seizures (EMAS) are likely to be switched to another diagnosis over time, according to a retrospective chart analysis of 77 children at Children’s Hospital of Colorado.

  • Over 50% of patients in this study were switched from suspected EMAS to another epilepsy diagnosis.
  • Among the 77 patients, 30 had an initial diagnosis of EMAS and 57 had a final diagnosis of EMAS.
  • Among 65% of patients who had more than one diagnosis over time, the first, second, and third diagnoses were provided within 1 year, 3 years, and 10 years after the onset of the disease.
  • Signs of Lennox-Gastaut syndrome (LGS), including paroxysmal fast activity, slow spike-and-wave, and tonic seizure, were detected in 50% of the 77 patients but only a minority received a final diagnosis of LGS.

Eschbach K., Moss A, Joshi C, et al. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 2018; 147:95-101. https://doi.org/10.1016/j.eplepsyres.2018.09.011

Publications
Topics
Sections
Epilepsy Res; 2018 Nov; Eschbach et al.
Epilepsy Res; 2018 Nov; Eschbach et al.

Pediatric patients who have been initially diagnosed with epilepsy with myoclonic-atonic seizures (EMAS) are likely to be switched to another diagnosis over time, according to a retrospective chart analysis of 77 children at Children’s Hospital of Colorado.

  • Over 50% of patients in this study were switched from suspected EMAS to another epilepsy diagnosis.
  • Among the 77 patients, 30 had an initial diagnosis of EMAS and 57 had a final diagnosis of EMAS.
  • Among 65% of patients who had more than one diagnosis over time, the first, second, and third diagnoses were provided within 1 year, 3 years, and 10 years after the onset of the disease.
  • Signs of Lennox-Gastaut syndrome (LGS), including paroxysmal fast activity, slow spike-and-wave, and tonic seizure, were detected in 50% of the 77 patients but only a minority received a final diagnosis of LGS.

Eschbach K., Moss A, Joshi C, et al. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 2018; 147:95-101. https://doi.org/10.1016/j.eplepsyres.2018.09.011

Pediatric patients who have been initially diagnosed with epilepsy with myoclonic-atonic seizures (EMAS) are likely to be switched to another diagnosis over time, according to a retrospective chart analysis of 77 children at Children’s Hospital of Colorado.

  • Over 50% of patients in this study were switched from suspected EMAS to another epilepsy diagnosis.
  • Among the 77 patients, 30 had an initial diagnosis of EMAS and 57 had a final diagnosis of EMAS.
  • Among 65% of patients who had more than one diagnosis over time, the first, second, and third diagnoses were provided within 1 year, 3 years, and 10 years after the onset of the disease.
  • Signs of Lennox-Gastaut syndrome (LGS), including paroxysmal fast activity, slow spike-and-wave, and tonic seizure, were detected in 50% of the 77 patients but only a minority received a final diagnosis of LGS.

Eschbach K., Moss A, Joshi C, et al. Diagnosis switching and outcomes in a cohort of patients with potential epilepsy with myoclonic-atonic seizures. Epilepsy Res. 2018; 147:95-101. https://doi.org/10.1016/j.eplepsyres.2018.09.011

Publications
Publications
Topics
Article Type
Display Headline
Diagnosis of Epilepsy with Myoclonic-Atonic Seizures Often Changes
Display Headline
Diagnosis of Epilepsy with Myoclonic-Atonic Seizures Often Changes
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 10/24/2018 - 15:00
Un-Gate On Date
Wed, 10/24/2018 - 15:00
Use ProPublica
CFC Schedule Remove Status
Wed, 10/24/2018 - 15:00

Finding Better Way to Pinpoint Seizure Onset Zone

Article Type
Changed
Wed, 10/24/2018 - 14:52
Display Headline
Finding Better Way to Pinpoint Seizure Onset Zone
Epilepsy Res; 2018 Oct; Kuo et al.

Researchers have found that using 256-channel high-density EEG and high-resolution head models of individual patients can help establish precise electrical source imaging of oscillatory features of the onset of a seizure, which in turn improves presurgical planning. Precisely localizing the seizure onset zone in the cortex is important for the best surgical outcomes.

  • Using noninvasive electrical source imaging to plan surgery has proven problematic to date because of the interference of noise artifacts and non-seizure activity, which can be superimposed over the seizure signal.
  • In this study, high density EEG was combined with exact sensor positioning and individual electrical head models, which were derived from T1 MRI results.
  • Among 84 seizures, investigators were able to localize the onset of 56.
  • High density EEG with interictal spikes was more accurate than international 10-20 EEG for interictal spikes and ictal onset.

Kuo C-C, Tucker DM, Luu P, et al. EEG source imaging of epileptic activity at seizure onset. Epilepsy Res. 2018;146:160-171. https://doi.org/10.1016/j.eplepsyres.2018.07.006

Publications
Topics
Sections
Epilepsy Res; 2018 Oct; Kuo et al.
Epilepsy Res; 2018 Oct; Kuo et al.

Researchers have found that using 256-channel high-density EEG and high-resolution head models of individual patients can help establish precise electrical source imaging of oscillatory features of the onset of a seizure, which in turn improves presurgical planning. Precisely localizing the seizure onset zone in the cortex is important for the best surgical outcomes.

  • Using noninvasive electrical source imaging to plan surgery has proven problematic to date because of the interference of noise artifacts and non-seizure activity, which can be superimposed over the seizure signal.
  • In this study, high density EEG was combined with exact sensor positioning and individual electrical head models, which were derived from T1 MRI results.
  • Among 84 seizures, investigators were able to localize the onset of 56.
  • High density EEG with interictal spikes was more accurate than international 10-20 EEG for interictal spikes and ictal onset.

Kuo C-C, Tucker DM, Luu P, et al. EEG source imaging of epileptic activity at seizure onset. Epilepsy Res. 2018;146:160-171. https://doi.org/10.1016/j.eplepsyres.2018.07.006

Researchers have found that using 256-channel high-density EEG and high-resolution head models of individual patients can help establish precise electrical source imaging of oscillatory features of the onset of a seizure, which in turn improves presurgical planning. Precisely localizing the seizure onset zone in the cortex is important for the best surgical outcomes.

  • Using noninvasive electrical source imaging to plan surgery has proven problematic to date because of the interference of noise artifacts and non-seizure activity, which can be superimposed over the seizure signal.
  • In this study, high density EEG was combined with exact sensor positioning and individual electrical head models, which were derived from T1 MRI results.
  • Among 84 seizures, investigators were able to localize the onset of 56.
  • High density EEG with interictal spikes was more accurate than international 10-20 EEG for interictal spikes and ictal onset.

Kuo C-C, Tucker DM, Luu P, et al. EEG source imaging of epileptic activity at seizure onset. Epilepsy Res. 2018;146:160-171. https://doi.org/10.1016/j.eplepsyres.2018.07.006

Publications
Publications
Topics
Article Type
Display Headline
Finding Better Way to Pinpoint Seizure Onset Zone
Display Headline
Finding Better Way to Pinpoint Seizure Onset Zone
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 10/24/2018 - 14:45
Un-Gate On Date
Wed, 10/24/2018 - 14:45
Use ProPublica
CFC Schedule Remove Status
Wed, 10/24/2018 - 14:45

Unique MRI Findings in Juvenile Myoclonic Epilepsy

Article Type
Changed
Wed, 10/24/2018 - 14:52
Display Headline
Unique MRI Findings in Juvenile Myoclonic Epilepsy
Epilepsia; ePub 2018 Oct 3; Garcia-Ramos et al.

The cortical regions of the brains of patients with juvenile myoclonic epilepsy (JME) are more likely to be disassociated from subcortical structures, according to a recent study that compared the MRI readings of JME patients to those of normal children. 

  • Investigators from the University of Wisconsin School of Medicine compared 21 children with JME to 22 healthy controls over a 2 year period.
  • Normal children had modular cortical development and network integration between cortical and subcortical regions.
  • Patients with epilepsy had a less modular cortical network that was disassociated from subcortical structures.
  • Children with JME were also found to have weaker modules or communities, as indicated by higher clustering and lower modularity indices.

 

Garcia-Ramos C, Dabbs K, Lin JJ, et al. Progressive dissociation of cortical and subcortical network development in children with newonset juvenile myoclonic epilepsy [Published online ahead of print Oct 3, 2018]. Epilepsia.  https://doi.org/10.1111/epi.14560

Publications
Topics
Sections
Epilepsia; ePub 2018 Oct 3; Garcia-Ramos et al.
Epilepsia; ePub 2018 Oct 3; Garcia-Ramos et al.

The cortical regions of the brains of patients with juvenile myoclonic epilepsy (JME) are more likely to be disassociated from subcortical structures, according to a recent study that compared the MRI readings of JME patients to those of normal children. 

  • Investigators from the University of Wisconsin School of Medicine compared 21 children with JME to 22 healthy controls over a 2 year period.
  • Normal children had modular cortical development and network integration between cortical and subcortical regions.
  • Patients with epilepsy had a less modular cortical network that was disassociated from subcortical structures.
  • Children with JME were also found to have weaker modules or communities, as indicated by higher clustering and lower modularity indices.

 

Garcia-Ramos C, Dabbs K, Lin JJ, et al. Progressive dissociation of cortical and subcortical network development in children with newonset juvenile myoclonic epilepsy [Published online ahead of print Oct 3, 2018]. Epilepsia.  https://doi.org/10.1111/epi.14560

The cortical regions of the brains of patients with juvenile myoclonic epilepsy (JME) are more likely to be disassociated from subcortical structures, according to a recent study that compared the MRI readings of JME patients to those of normal children. 

  • Investigators from the University of Wisconsin School of Medicine compared 21 children with JME to 22 healthy controls over a 2 year period.
  • Normal children had modular cortical development and network integration between cortical and subcortical regions.
  • Patients with epilepsy had a less modular cortical network that was disassociated from subcortical structures.
  • Children with JME were also found to have weaker modules or communities, as indicated by higher clustering and lower modularity indices.

 

Garcia-Ramos C, Dabbs K, Lin JJ, et al. Progressive dissociation of cortical and subcortical network development in children with newonset juvenile myoclonic epilepsy [Published online ahead of print Oct 3, 2018]. Epilepsia.  https://doi.org/10.1111/epi.14560

Publications
Publications
Topics
Article Type
Display Headline
Unique MRI Findings in Juvenile Myoclonic Epilepsy
Display Headline
Unique MRI Findings in Juvenile Myoclonic Epilepsy
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Wed, 10/24/2018 - 14:45
Un-Gate On Date
Wed, 10/24/2018 - 14:45
Use ProPublica
CFC Schedule Remove Status
Wed, 10/24/2018 - 14:45

Pediatric Status Epilepticus Takes Heavy Toll

Article Type
Changed
Mon, 10/08/2018 - 11:05
Display Headline
Pediatric Status Epilepticus Takes Heavy Toll
Seizure; ePub 2018 Aug; Gurcharran et al.

Pediatric status epilepticus (SE) is an expensive disorder and is not uncommon in this patient population, according to a recent review of the medical literature.

  • Gurcharran et al note that pediatric SE occurs in about 20per 100,000 children each year.
  • The disorder carries a mortality of 3%.
  • The most common risk factor for morbidity and death is symptomatic etiology, with acute presentation more common than remote.
  • A single episode of status epilepticus costs more than $10,000 to manage and can reach more than $100,000 in children with refractory disease.
  • The most common cause of the condition is febrile SE, which usually occurs in early childhood.

 

Gurcharran K, Grinspan ZM. The burden of pediatric status epilepticus: epidemiology, morbidity, and mortality. [Published online ahead of print August 29, 2018] Seizure. https://doi.org/10.1016/j.seizure.2018.08.021.

Publications
Topics
Sections
Seizure; ePub 2018 Aug; Gurcharran et al.
Seizure; ePub 2018 Aug; Gurcharran et al.

Pediatric status epilepticus (SE) is an expensive disorder and is not uncommon in this patient population, according to a recent review of the medical literature.

  • Gurcharran et al note that pediatric SE occurs in about 20per 100,000 children each year.
  • The disorder carries a mortality of 3%.
  • The most common risk factor for morbidity and death is symptomatic etiology, with acute presentation more common than remote.
  • A single episode of status epilepticus costs more than $10,000 to manage and can reach more than $100,000 in children with refractory disease.
  • The most common cause of the condition is febrile SE, which usually occurs in early childhood.

 

Gurcharran K, Grinspan ZM. The burden of pediatric status epilepticus: epidemiology, morbidity, and mortality. [Published online ahead of print August 29, 2018] Seizure. https://doi.org/10.1016/j.seizure.2018.08.021.

Pediatric status epilepticus (SE) is an expensive disorder and is not uncommon in this patient population, according to a recent review of the medical literature.

  • Gurcharran et al note that pediatric SE occurs in about 20per 100,000 children each year.
  • The disorder carries a mortality of 3%.
  • The most common risk factor for morbidity and death is symptomatic etiology, with acute presentation more common than remote.
  • A single episode of status epilepticus costs more than $10,000 to manage and can reach more than $100,000 in children with refractory disease.
  • The most common cause of the condition is febrile SE, which usually occurs in early childhood.

 

Gurcharran K, Grinspan ZM. The burden of pediatric status epilepticus: epidemiology, morbidity, and mortality. [Published online ahead of print August 29, 2018] Seizure. https://doi.org/10.1016/j.seizure.2018.08.021.

Publications
Publications
Topics
Article Type
Display Headline
Pediatric Status Epilepticus Takes Heavy Toll
Display Headline
Pediatric Status Epilepticus Takes Heavy Toll
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 10/08/2018 - 11:00
Un-Gate On Date
Mon, 10/08/2018 - 11:00
Use ProPublica
CFC Schedule Remove Status
Mon, 10/08/2018 - 11:00

Are New Treatments for Pediatric Refractory Status Epilepticus Effective?

Article Type
Changed
Mon, 10/08/2018 - 11:05
Display Headline
Are New Treatments for Pediatric Refractory Status Epilepticus Effective?
Seizure; ePub 2018 Sept; Arya et al.

While several emerging treatments have been recommended for children with refractory status epilepticus, most of the research supporting these modalities are anecdotal in nature, according to a review published in Seizure.

  • Randomized controlled trials have evaluated hypothermia and found it is no more effective than placebo for refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE).
  • Case series have suggested that a ketogenic diet may benefit children with RSE.
  • A few case reports involving the ketogenic diet found seizures were stopped within a week in 20-90% of children.
  • One double blind trial concluded that brexanolone was no more effective than placebo for weaning patients off 3rd line anesthetic agents and freedom from RSE after 24 hours.

Arya R, Rotenberg A.  Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus.  [Published online ahead of print Sept 14, 2018]. Seizure. https://doi.org/10.1016/j.seizure.2018.09.002.

Publications
Topics
Sections
Seizure; ePub 2018 Sept; Arya et al.
Seizure; ePub 2018 Sept; Arya et al.

While several emerging treatments have been recommended for children with refractory status epilepticus, most of the research supporting these modalities are anecdotal in nature, according to a review published in Seizure.

  • Randomized controlled trials have evaluated hypothermia and found it is no more effective than placebo for refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE).
  • Case series have suggested that a ketogenic diet may benefit children with RSE.
  • A few case reports involving the ketogenic diet found seizures were stopped within a week in 20-90% of children.
  • One double blind trial concluded that brexanolone was no more effective than placebo for weaning patients off 3rd line anesthetic agents and freedom from RSE after 24 hours.

Arya R, Rotenberg A.  Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus.  [Published online ahead of print Sept 14, 2018]. Seizure. https://doi.org/10.1016/j.seizure.2018.09.002.

While several emerging treatments have been recommended for children with refractory status epilepticus, most of the research supporting these modalities are anecdotal in nature, according to a review published in Seizure.

  • Randomized controlled trials have evaluated hypothermia and found it is no more effective than placebo for refractory status epilepticus (RSE) and super-refractory status epilepticus (SRSE).
  • Case series have suggested that a ketogenic diet may benefit children with RSE.
  • A few case reports involving the ketogenic diet found seizures were stopped within a week in 20-90% of children.
  • One double blind trial concluded that brexanolone was no more effective than placebo for weaning patients off 3rd line anesthetic agents and freedom from RSE after 24 hours.

Arya R, Rotenberg A.  Dietary, immunological, surgical, and other emerging treatments for pediatric refractory status epilepticus.  [Published online ahead of print Sept 14, 2018]. Seizure. https://doi.org/10.1016/j.seizure.2018.09.002.

Publications
Publications
Topics
Article Type
Display Headline
Are New Treatments for Pediatric Refractory Status Epilepticus Effective?
Display Headline
Are New Treatments for Pediatric Refractory Status Epilepticus Effective?
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 10/08/2018 - 11:00
Un-Gate On Date
Mon, 10/08/2018 - 11:00
Use ProPublica
CFC Schedule Remove Status
Mon, 10/08/2018 - 11:00

Cross Sensitivity of Antiepileptic Side Effects

Article Type
Changed
Mon, 10/08/2018 - 11:04
Display Headline
Cross Sensitivity of Antiepileptic Side Effects
Seizure; ePub 2018 Sept; Chen et al.

Patients will likely develop intolerable psychiatric and behavioral side effects (IPBSE) to an antiepileptic drug if they are already sensitive to another one, according to researchers from Yale and Columbia University.

  • A review of the records of over 2,000 patients found that about 20% were taking at least two antiepileptic drug and had at IPBSE to at least one of the drugs.
  • Cross sensitivity was detected between zonisamide and levetiracetam.
  • The odds of developing said side effects from levetiracetam or from zonisamide were significantly higher in a patient that had had a side effect to another antiepileptic drug than in patients who had no IPBSE to other antiepileptic drugs (20.5% versus 7.5%.)
  •  A history of depression and psychosis increase the risk of IPBSE among patients taking antiepileptic medication.

 

Chen B, Choi H, Hirsch LJ, et al. Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use. [Published online ahead of print Sept 22, 2018]. Seizure. https://doi.org/10.1016/j.seizure.2018.09.014.

Publications
Topics
Sections
Seizure; ePub 2018 Sept; Chen et al.
Seizure; ePub 2018 Sept; Chen et al.

Patients will likely develop intolerable psychiatric and behavioral side effects (IPBSE) to an antiepileptic drug if they are already sensitive to another one, according to researchers from Yale and Columbia University.

  • A review of the records of over 2,000 patients found that about 20% were taking at least two antiepileptic drug and had at IPBSE to at least one of the drugs.
  • Cross sensitivity was detected between zonisamide and levetiracetam.
  • The odds of developing said side effects from levetiracetam or from zonisamide were significantly higher in a patient that had had a side effect to another antiepileptic drug than in patients who had no IPBSE to other antiepileptic drugs (20.5% versus 7.5%.)
  •  A history of depression and psychosis increase the risk of IPBSE among patients taking antiepileptic medication.

 

Chen B, Choi H, Hirsch LJ, et al. Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use. [Published online ahead of print Sept 22, 2018]. Seizure. https://doi.org/10.1016/j.seizure.2018.09.014.

Patients will likely develop intolerable psychiatric and behavioral side effects (IPBSE) to an antiepileptic drug if they are already sensitive to another one, according to researchers from Yale and Columbia University.

  • A review of the records of over 2,000 patients found that about 20% were taking at least two antiepileptic drug and had at IPBSE to at least one of the drugs.
  • Cross sensitivity was detected between zonisamide and levetiracetam.
  • The odds of developing said side effects from levetiracetam or from zonisamide were significantly higher in a patient that had had a side effect to another antiepileptic drug than in patients who had no IPBSE to other antiepileptic drugs (20.5% versus 7.5%.)
  •  A history of depression and psychosis increase the risk of IPBSE among patients taking antiepileptic medication.

 

Chen B, Choi H, Hirsch LJ, et al. Cross-sensitivity of psychiatric and behavioral side effects with antiepileptic drug use. [Published online ahead of print Sept 22, 2018]. Seizure. https://doi.org/10.1016/j.seizure.2018.09.014.

Publications
Publications
Topics
Article Type
Display Headline
Cross Sensitivity of Antiepileptic Side Effects
Display Headline
Cross Sensitivity of Antiepileptic Side Effects
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Mon, 10/08/2018 - 11:00
Un-Gate On Date
Mon, 10/08/2018 - 11:00
Use ProPublica
CFC Schedule Remove Status
Mon, 10/08/2018 - 11:00

Disrupted Sleep, Cardiorespiratory Dysfunction Linked to SUDEP

Article Type
Changed
Fri, 09/28/2018 - 09:43
Display Headline
Disrupted Sleep, Cardiorespiratory Dysfunction Linked to SUDEP
Epilepsy Behav; 2018 Oct; Billakota et al.

Periictal cardiorespiratory dysfunction, sleep-disordered breathing, and endocrine dysfunction have all been linked to sudden unexpected death from epilepsy (SUDEP).

  • Investigators conducted a prospective observational study on 30 patients in the Columbia University Medical Center’s adult epilepsy monitoring unit.
  • Their analysis found that patients who were at high risk for SUDEP were more likely to experience cardiorespiratory dysfunction (60% vs 27%).
  • Sleep-disordered breathing was found in 88% of patients with inpatient or outpatient polysomnography results that were fully scorable.
  • The researchers also found endocrine dysfunction in 35% of patients, with men more likely to experience the problem.
  • The analysis did not detect a significant relationship between cardiorespiratory dysfunction, sleep-disordered breathing, and neuroendocrine status.

 

Billakota S, Odom N, Westwood AJ, et al. Sleep-disordered breathing, neuroendocrine function, and clinical SUDEP risk in patients with epilepsy. Epilepsy Behav. 2018;87:78-82.

Publications
Topics
Sections
Epilepsy Behav; 2018 Oct; Billakota et al.
Epilepsy Behav; 2018 Oct; Billakota et al.

Periictal cardiorespiratory dysfunction, sleep-disordered breathing, and endocrine dysfunction have all been linked to sudden unexpected death from epilepsy (SUDEP).

  • Investigators conducted a prospective observational study on 30 patients in the Columbia University Medical Center’s adult epilepsy monitoring unit.
  • Their analysis found that patients who were at high risk for SUDEP were more likely to experience cardiorespiratory dysfunction (60% vs 27%).
  • Sleep-disordered breathing was found in 88% of patients with inpatient or outpatient polysomnography results that were fully scorable.
  • The researchers also found endocrine dysfunction in 35% of patients, with men more likely to experience the problem.
  • The analysis did not detect a significant relationship between cardiorespiratory dysfunction, sleep-disordered breathing, and neuroendocrine status.

 

Billakota S, Odom N, Westwood AJ, et al. Sleep-disordered breathing, neuroendocrine function, and clinical SUDEP risk in patients with epilepsy. Epilepsy Behav. 2018;87:78-82.

Periictal cardiorespiratory dysfunction, sleep-disordered breathing, and endocrine dysfunction have all been linked to sudden unexpected death from epilepsy (SUDEP).

  • Investigators conducted a prospective observational study on 30 patients in the Columbia University Medical Center’s adult epilepsy monitoring unit.
  • Their analysis found that patients who were at high risk for SUDEP were more likely to experience cardiorespiratory dysfunction (60% vs 27%).
  • Sleep-disordered breathing was found in 88% of patients with inpatient or outpatient polysomnography results that were fully scorable.
  • The researchers also found endocrine dysfunction in 35% of patients, with men more likely to experience the problem.
  • The analysis did not detect a significant relationship between cardiorespiratory dysfunction, sleep-disordered breathing, and neuroendocrine status.

 

Billakota S, Odom N, Westwood AJ, et al. Sleep-disordered breathing, neuroendocrine function, and clinical SUDEP risk in patients with epilepsy. Epilepsy Behav. 2018;87:78-82.

Publications
Publications
Topics
Article Type
Display Headline
Disrupted Sleep, Cardiorespiratory Dysfunction Linked to SUDEP
Display Headline
Disrupted Sleep, Cardiorespiratory Dysfunction Linked to SUDEP
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Gate On Date
Fri, 09/28/2018 - 09:45
Un-Gate On Date
Fri, 09/28/2018 - 09:45
Use ProPublica
CFC Schedule Remove Status
Fri, 09/28/2018 - 09:45